Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Omega DUROS device · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Omega DUROS: Dose 25 |
| 2 | EXPERIMENTAL | Omega DUROS: Dose 50 |
| Name | Type | Description |
|---|---|---|
| Omega DUROS device | DRUG | Omega DUROS device 25mcg inserted SC for 48 weeks Omega DUROS device 50mcg inserted SC for 48 weeks |
Inclusion Criteria: * Chronic Hepatitis C with HCV genotype 1 infection * Relapse following an end of treatment response after treatment with a pegylated interferon and ribavirin. Exclusion Criteria: * Presence or history of non-HCV chronic liver disease * Treatment with any interferon subsequent...
Omega DUROS device is an investigational small molecule being developed for the treatment of chronic Hepatitis C. It is designed for patients who have relapsed after prior treatment. The device is currently in Phase 1 clinical development and is not yet approved by regulatory authorities.
Omega DUROS device is being developed by cbdMD, Inc., a company traded on the stock exchange under the ticker symbol YCBD. The company is conducting clinical research to evaluate the safety and efficacy of this investigational therapy for chronic Hepatitis C.
Omega DUROS device is in Phase 1 clinical development. A Phase 1b study has been completed, which involved 60 participants with chronic Hepatitis C who had relapsed after prior treatment. The drug remains investigational and has not received FDA approval.
Omega DUROS device has one completed clinical trial registered as NCT00519792. This was a Phase 1b study conducted in the United States and Puerto Rico, enrolling 60 adults with chronic Hepatitis C who had relapsed after prior treatment. The trial was controlled and randomized.
Yes, Omega DUROS device is the same as Omega DUROS. The clinical trial NCT00519792 refers to the study as 'Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment.' Both names refer to the same investigational product.